Intrinsic Heat Stability of a Phytase

reading time
Article | 19.12.2021
An additional criterion for a good phytase

Lode Nollet MSc, PhD.


The biochemical characterisation of a phytase such as pH profile, pepsin resistance, speed and affinity, can provide information on the potential efficacy of the phytase in vivo. The focus on improvement of the intrinsic heat stability has been driven by the market and forms part of the selection criteria. 


Exogenous added phytase in feed has already been in practice for more than 25 years. It is used to liberate phosphorus (P) bound to phytate present in raw materials, lowering the feed cost by reducing the amount of added inorganic P and to degrade the concentration of phytate, a well-known anti-nutritional factor. 

At the same time, environmental sustainability is improved, as P excretion in the environment is reduced. Also, awareness is growing that the sources of inorganic P are not inexhaustible.

As different phytases are commercially available, it is important to understand which criteria are important to make a good choice.

pH profile and pepsin resistance of the phytase

These criteria have already been used for a long time as a first quick screening of phytases. It is common knowledge that phytase must be in solution to allow the exogenous phytase to hydrolyse its phosphate groups. Phytate is largely soluble at pH levels below 4.0 (gizzard) while at higher pH levels it forms complexes with positively charged ions and amino acids, making it insoluble and unavailable for hydrolysis by phytase. Therefore, a phytase with a high activity throughout the complete acid pH range from pH 2 to 4 has shown to be superior. As phytases work in the gizzard, screening for a phytase which is not prone to degradation by pepsin is also an important parameter to consider.

Speed of phytate hydrolysis and affinity for phytate

A key criterion for selection is speed of phytate hydrolysis. The aim is to have a maximal speed so that quick degradation of phytate is achieved. This is not only providing a high P release in a short time, but the destruction of phytate also leads to the release of micro-minerals and proteins (amino acids) complexed by it, enhancing their digestibility. This maximal speed (Vmax) is determined in so-called Michaelis Menten kinetic studies, in which the speed of phytate degradation is measured with increasing levels of phytate in vitro (Figure 1). 

Figure 1. The speed of phytate degradation by two phytases showing equal maximal speed (Vmax) but a different affinity (Km) for phytate

However, as indicated in Figure 1, two phytases having a similar Vmax can have lower speed of action when phytate levels decrease due to the action of the phytase. This is due to a difference in affinity (Km) of the phytase for phytate. The affinity, defined as the concentration of phytate at which the speed of its degradation equals half of its maximal speed, indicates how long this high speed can be maintained when the phytate concentration is decreasing. A low Km (so a high affinity) gives a benefit to a phytase as it will lead to a prolonged high speed of phytate degradation, and thus a higher P matrix value measured in vivo can be expected.

Translating this into a practical situation: when birds consume feed, the initial phytate level will drop during hydrolysis in the gizzard, and so will the speed of phytate degradation. A phytase with a higher affinity (a lower Km) will be able to keep the high speed of phytate degradation up for a longer time, and will thereby give a higher P matrix value.

Striving for an intrinsic heat stable phytase

The first phytases commercialised 20-30 years ago were rather heat sensitive during pelleting, even when coated, requiring post-pellet liquid application (PPLA) of the phytase. Next to the cost of installation, the risk of this equipment malfunctioning lurked around the corner requiring a high level of maintenance and quality control which is a burden to the feed mill manager and technician.

In that perspective, the intrinsic heat stability of a phytase gained interest. An increase in intrinsic heat stability that allows pelleting up to 85 oC was a reassuring level of thermostability under normal pelleting conditions. When, by a coating technique, the thermostability could be increased to 90 oC (or even 95 oC), an alternative to the application of liquid phytases through PPLA was realised.

In the period 2017-2020, plural pelleting trials in Europe (at five different trial locations) and in the USA (at five different trial locations) were conducted to assess the heat stability of a newly developed intrinsic heat stable phytase, either uncoated (granular) as well as the coated version. It was chosen to run these trials in different trial locations, so that the phytase was tested under a wide variety of different pelleting conditions (including impacting factors like equipment, feed composition, speed of cooling and others). As the universal definition of stability states that "stability is achieved when recovery of the active substance is > 80% of the original value", it can be seen that the newly developed phytase can claim an intrinsic heat stability of 85 oC (Figure 2) when applied in the granular form (G), while its coated version (CT) can stand pelleting temperatures up to 90 oC and even 95 oC with acceptable (25%) losses of activity (Figure 2). 

Figure 2. Average recovery of pelleting studies ran with a granular and coated intrinsic heat stable phytase (2017 to 2020, EU and the USA)


Next to the screening for optimal biochemical characteristics of a phytase like pH profile, pepsin resistance and speed/affinity, the intrinsic heat stability has become a prerequisite for a phytase, allowing it to reach a heat stability up to 85 oC and even up to 95 oC when appropriately coated.


Lode Nollet MSc., PhD is Global Product Manager Enymes, responsible for the scientific and marketing support of Huvepharma's enzyme portfolio worldwide.
global presence

Local support from a global company

Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
about us


Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us

Change country

The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.

To view all products and services, select Global from the dropdown menu or click .




North America


South America

Change language

Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.


United States

Click here to visit the local website or close this popup to stay on the global website.

Your browser is out of date!

Update your browser to view this website correctly. Update my browser now